1887

oa Journal of Marketing - The pitfalls of pharmaceutical marketing

Volume 2008, Issue 02
  • ISSN : 1811-9565

 

Abstract

During 2007, Adcock Ingram incurred the wrath of the Medicines Control Council when it advertised its flagship product, Myprodol, directly to consumers. According to the Medicines Act, pharmaceutical products classified as schedule two or higher may not be advertised directly to the public, but only to medical practitioners, pharmacists and individuals authorized to prescribe prescription drugs. Classified as a schedule three drug, Myprodol falls into this restricted category.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/mfsa1/2008/02/EJC74804
2008-02-01
2016-12-10

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error